Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.44 |
| ▸ | PDE2A | O00408 | 7/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.41 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | ACP3 | P15309 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.38 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.38 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.38 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.38 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.38 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5608985 | 0.82 | GRIA4 (0.41) | PDE2AAKR1C3AKR1C2KIF11FFAR1 | |
| SCHEMBL27744109 | 0.79 | CES2 (0.44) | FBP1PDE2AAKR1C3AKR1C2CES2 | |
| SCHEMBL18632149 | 0.78 | L3MBTL1 (0.41) | FBP1 | |
| SCHEMBL9341632 | 0.77 | FBP1 (0.41) | FBP1PDE2ACES2CES1CA1 | |
| SCHEMBL1983288 | 0.77 | CA1 (0.43) | FBP1PDE2ACES2CES1CA1 | |
| SCHEMBL17018447 | 0.75 | ACHE (0.48) | FBP1NPC1RAB9A | |
| SCHEMBL4087041 | 0.74 | ALDH1A1 (0.46) | CA1CA2NPC1RAB9A | |
| SCHEMBL264810 | 0.74 | ADRB2 (0.46) | FBP1 | |
| SCHEMBL27496184 | 0.74 | HSD17B10 (0.52) | CES1CA1CA2NPC1 | |
| SCHEMBL12983360 | 0.74 | CYP1A2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | TDK CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
| CN-116981657-A | Fluorine-containing compound and contrast agent | TDK株式会社 | 2023-10-31 | — | — | CN | disclosed |
| WO-2022196734-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | TDK株式会社 | 2022-09-22 | — | — | WO | disclosed |
| EP-1655070-B1 | OXIDATION CATALYST | ASAHI KASEI CHEMICALS CORP (JP) | 2015-07-15 | — | — | EP | disclosed |
| US-8133834-B2 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100069670-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20060229471-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2006-10-12 | — | — | US | disclosed |
| EP-1655070-A1 | OXIDATION CATALYST | Asahi Kasei Chemicals Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240156994-A1 | FLUORINE-CONTAINING COMPOUND AND CONTRAST MEDIUM | AFF1, AFF2, AFF4 | FBP1 97/4885PDE2A 1515/4885AKR1C3 2280/4885 |
| US-20100069670-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | FBP1 1940/4885PDE2A 3641/4885AKR1C3 1187/4885 |
| US-20060229471-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | FBP1 1940/4885PDE2A 3641/4885AKR1C3 1187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.